Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
The first time thinking about health economics and workforce solutions
+Practice
First Time
The first time thinking about health economics and workforce solutions
Tuesday 15 April 2025, 12:35 AM

A second-hand car may be cheap, but if it breaks down all the time, it wasn’t value for money [Image: Towfiqu barbhuiya on Unsplash]
Specialist GP Jo Scott-Jones discusses health economics and considers whether cost–utility analyses could help plan for the workforce of the future
Key points, In health economics, the quality-adjusted life year is used to measure the outcome of an intervention in terms of the quantity and quality of life it , Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Pharmac. Cost-Utility Analysis (CUA) Explained. August 2015.
2. New Zealand Infrastructure Commission. Discover the Strategy. 6. A thriving New Zealand: what we need to do.
3. Sapere. Memorandum. Re: Waikato Medical School cost-benefit analysis: comments on Minister Seymour’s letter of 21 August 2024. 22 August 2024.